Interacting Drugs |
Pegylated interferon (peginterferon) alfa-2b vs CYP2D6 Substrates |
Security Level |
|
Mechanism |
CYP2D6 Substrates: Peginterferon Alfa-2b may decrease the serum concentration of CYP2D6 Substrates. Exceptions: Betaxolol (Ophthalmic); Carteolol (Ophthalmic); Timolol (Ophthalmic). |
Management |
Monitor therapy |
Pegylated interferon (peginterferon) alfa-2b vs CYP2D6 Substrates
Post Review about Pegylated interferon (peginterferon) alfa-2b vs CYP2D6 Substrates Click here to cancel reply.
Other Interactions of Pegylated interferon (peginterferon) alfa-2b
Other Interactions of CYP2D6 Substrates
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.